Unknown Leptospirosis Vaccine

Verify with FDA CVM →

11 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
11
Total Reports
2
Deaths Reported
1820.0%
Death Rate

Active Ingredients

Unknown Leptospirosis Vaccine

Administration Routes

UnknownOtherSubcutaneous

Species Affected

Dog 11

Most Affected Breeds

Retriever - Labrador 3
Beagle 1
Shih Tzu 1
Mastiff (unspecified) 1
Terrier - Bull - American Pit 1
Retriever - Golden 1
Shepherd Dog - German 1
Shiba Inu 1
Coonhound - Black and Tan 1

Most Reported Reactions

Urinary tract infection 3
Elevated liver enzymes 2
Appetite loss 2
Elevated total bilirubin 2
Ascites 2
Renal failure 2
Liver disorder NOS 2
Discoloured urine 2
Constipation 2
Hair shedding 2
Death by euthanasia 2
Liver failure 2

Outcome Breakdown

Outcome Unknown
4 (36.4%)
Ongoing
4 (36.4%)
Euthanized
2 (18.2%)
Recovered/Normal
1 (9.1%)

Data Summary

Metric Value
Total adverse event reports 11
Reports involving death 2
Case-fatality rate (reported events) 1820.0%
Distinct species in reports 1
Distinct breeds in reports 9
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Unknown Leptospirosis Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 11 adverse event reports referencing Unknown Leptospirosis Vaccine, including 2 reports in which the animal died — a 1820.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Unknown Leptospirosis Vaccine. Reported administration routes include Unknown, Other, Subcutaneous. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Unknown Leptospirosis Vaccine reports are Dog (11 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (3), Beagle (1), Shih Tzu (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Unknown Leptospirosis Vaccine are Urinary tract infection (3), Elevated liver enzymes (2), Appetite loss (2), Elevated total bilirubin (2). Of the 11 reports with a coded outcome, Outcome Unknown is the leading category at 36.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Unknown Leptospirosis Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial